Finance

Lists
Why is 1IY0 down 5,87%?
Dive Deeper
1IY0:FRA
Monopar Therapeutics Inc
€69,00
-5,87%
(-4,30) 1D
12 Okt., 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 1IY0...
Open
€69,00
High
€69,00
Low
€69,00
Mkt. cap
517,17 m
Avg. vol.
0,00
Volume
0,00
52-wk high
€103,40
52-wk low
€41,70
No. of employees
22
Open
€69,00
High
€69,00
Low
€69,00
Mkt. cap
517,17 m
Avg. vol.
0,00
Volume
0,00
52-wk high
€103,40
52-wk low
€41,70
No. of employees
22
News stories
From web sources and news partners
About Monopar Therapeutics Inc
CEO-
Employees22
Founded2014
HeadquartersWilmette, Illinois, Verenigde State van Amerika
Sector-
Websitemonopartx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2,59 m
3,94 m
3,49 m
4,77 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,50 m
2,21 m
1,74 m
1,88 m
Operating expense
4,09 m
6,16 m
5,23 m
6,64 m
Total operating expenses
4,09 m
6,16 m
5,23 m
6,64 m
Operating income
-4,09 m
-6,16 m
-5,23 m
-6,64 m
Other non operating income
1,00
-1,00
-
32,16 k
EBT including unusual items
-3,44 m
-5,20 m
-3,89 m
-5,31 m
EBT excluding unusual items
-3,44 m
-5,20 m
-3,89 m
-5,31 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3,44 m
-5,20 m
-3,89 m
-5,31 m
Net profit margin
-
-
-
-
Earnings per share
-0,48
-0,61
-0,46
-0,62
Interest and investment income
655,47 k
954,43 k
1,33 m
1,30 m
Interest expense
-
-
-
-
Net interest expenses
655,47 k
954,43 k
1,33 m
1,30 m
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme